Kuros Biosciences AG (CSBTF)

Kuros Biosciences AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,000	889	152	58	69	75
Market Cap Growth	954.40%	483.56%	162.24%	-16.11%	-7.51%	31.82%
Enterprise Value	980	875	136	37	42	61
Last Close Price	26.13	22.57	3.85	1.92	2.55	2.40
PS Ratio	11.99	10.66	3.82	2.99	4.57	16.40
PB Ratio	15.42	13.71	2.26	0.78	0.82	0.78
P/TBV Ratio	37.24	33.12	8.15	2.67	3.01	2.45
P/FCF Ratio	442.96	393.96	-	-	-	-
P/OCF Ratio	288.49	256.57	-	-	-	-
EV/Sales Ratio	10.74	10.50	3.41	1.90	2.77	13.27
EV/EBITDA Ratio	298.38	385.86	-	-	-	-
EV/EBIT Ratio	-	7414.24	-	-	-	-
EV/FCF Ratio	434.28	387.93	-	-	-	-
Debt / Equity Ratio	0.03	0.03	0.04	0.03	0.03	0.03
Debt / EBITDA Ratio	0.66	0.66	-	-	-	-
Debt / FCF Ratio	0.88	0.88	-	-	-	-
Asset Turnover	0.97	0.97	0.44	0.21	0.15	0.04
Inventory Turnover	1.18	1.18	1.27	1.47	2.33	1.96
Quick Ratio	1.64	1.64	2.22	2.20	2.72	7.69
Current Ratio	2.14	2.14	2.77	2.49	2.91	8.76
Return on Equity (ROE)	-6.44%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%
Return on Assets (ROA)	0.09%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%
Return on Capital (ROIC)	0.11%	0.11%	-4.90%	-8.21%	-6.59%	-8.81%
Return on Capital Employed (ROCE)	0.20%	0.20%	-	-	-	-
Earnings Yield	-0.47%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%
FCF Yield	0.23%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%
Buyback Yield / Dilution	-3.76%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.